A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors | MicrobiomeTrials← Back to trialsNCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-07-01Est. Completion: 2027-05
Enrollment target: 420 participants Locations- City of Hope National Medical Center, Duarte, California, United States
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California, United States
- Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States
- Florida Cancer Specialists and Research Institute, St. Petersburg, Florida, United States
- University of Chicago Hospital, Chicago, Illinois, United States
- IU Simon Cancer Center, Indianapolis, Indiana, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids, Michigan, United States
- Washington University School of Medicine in St. Louis, St Louis, Missouri, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Columbia University Irving Medical Center, New York, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Sarah Cannon Research Institute, Nashville, Tennessee, United States
- University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Metastatic Colorectal Cancer
CRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk. The purpose of…
Duarte, United StatesEst. completion Mar 2028
Metastatic Castration-resistant Prostate Cancer
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abira…
Goodyear, United StatesEst. completion Jan 7, 2030
South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United StatesUniversity of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United StatesSTART Mountain Region, West Valley City, Utah, United StatesSt Vincent's Hospital, Darlinghurst, AustraliaLinear Clinical Research, Nedlands, AustraliaBeijing Cancer hospital, Beijing, ChinaSun Yat-sen University Cancer Center, Guangzhou, ChinaRenji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaInstitut Gustave Roussy (Igr), Villejuif, FranceNational Cancer Center Hospital, Chūōku, JapanNational Cancer Center Hospital East, Kashiwa, Chiba, JapanThe Cancer Institute Hospital of JFCR, Kōtō City, JapanAichi Cancer Center Hospital, Nagoya, JapanAsan Medical Center, Seoul, South KoreaCatalan Institute of Oncology Duran i Reynals Hospital, Barcelona, SpainHospital Universitario 12 de Octubre, Madrid, SpainHospital Madrid Norte Sanchinarro, Madrid, SpainHospital Universitario Virgen Del Rocio, Seville, SpainSt Bartholomew's Hospital, London, United KingdomThe Christie NHS Foundation Trust, Manchester, United KingdomMetastatic Colorectal Cancer
Metastatic colorectal cancer or mCRC is a cancer that starts in the parts of the large intestine (the colon or rectum) a…
Multiple LocationsEst. completion Mar 31, 2028